MAPK3 and HIV infectious disease: This result suggests that HIV infection, together with increased cell activation, could functionally block intracellular MAP-ERK1/2-driven responses in CD8+ T cells, resulting in a reduction in T-cell proliferation, disruption of differentiation profiles, changes in apoptotic programs and alteration of effector functions (27).